ProteoNic BV


: Apr 4, 2017


Looking for Partnership Looking for Extra EU Funds
About Me

ProteoNic is seeking cooperation for the further advancement of its technology. ProteoNic is a life sciences company in possession of a validated and patented technology providing 2-3 times higher levels of recombinant proteins in mammalian cell vs. any current system. It is making license deals with pharma companies and CMO partners aiming for smarter, more cost-effective production of biopharmaceuticals. ProteoNic has collaborated in different European framework projects, for the development of cancer-specific antibodies.

Project activities and contributions offered to partner(s) comprise:

i) Production of recombinant biopharmaceutical proteins like biosimilars and difficult to express proteins in mammalian production hosts ( CHO GS), ii) development of new, genetically modified biopharmaceuticals, iii) expression construct development, iv) highly efficient screening for high-producing clones, v) biopharmaceutical protein production optimization as well as solving production and secretion issues.

Keywords and matching areas:

 Biological Sciences
 Biotechnology
 Medical Biotechnology
 Horizon Europe
 European Union
 INTERREG

Ideas in Progress

Favourite Calls
No Favourite calls!